Novel Regenerative Approaches for Osteoarthritis
A multinational biopharmaceutical company with long-standing presence in rheumatology and more recently, immuno-dermatology and bone disorders, are interested in the musculoskeletal area by exploring further indications in this space.
Osteoarthritis (OA) is a disease of high prevalence with high unmet need due to severe pain and joint impairment. It is a multifactorial and heterogenous disease where pathology is only partially understood. Current treatments focus on the pain aspect of the disease with no approved disease modifying therapies that promote ...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile